Similarly, our results showed that TCL+TIO3 obviously increased the percentage of CD4+ and CD8+ T cells in the lymphocytes of glioma-bearing mice (Figures 5C, D) compared with the TCL and PBS groups (p <0.001). This evidence concerns the gene CD4 and glioma.